[1]
J. Hernández Puentes, “Glucagon-like peptide-1 receptor agonist (GLP-1-RAS) treatment in patients with cirrhosis: A scoping review”, RJDNMD, vol. 31, no. 4, pp. 466-473, Dec. 2024.